GA HB968

Designates kratom alkaloid derivatives as Schedule I controlled substances, including 7-hydroxymitragynine (7-OH), mitragynine, MGM-15, MGM-16, 7-Acetoxymitragynine, and other synthetic or semisynthetic kratom derivatives

Restricts kratom sales to products grown in the United States, sold only in single-serving packaging (no multi-serving containers or pressed tablets), and kept behind counters with licensed pharmacists available for consultation

Requires real-time electronic logging of all kratom sales beginning January 1, 2027, with purchaser identification tracked and records maintained for two years with law enforcement access

Establishes concentration limits of no more than 150 mg mitragynine per serving and no more than 0.5 mg 7-hydroxymitragynine per gram, with mandatory labeling including pregnancy warnings and Georgia Poison Center contact information

Creates tiered penalties: processors face up to 15 years imprisonment and $100,000 fines for knowing violations; retailers face escalating fines from $250 to $5,000 with potential felony charges for repeat offenses; advertising violations carry $500 fines per offense with prohibitions on marketing to minors